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Abstract: Significance: Pupillometry protocols evaluating rod/cone- and melanopsin-driven
responses often utilize mydriatics to ensure maximal stimulus exposure; however,
retinal effects of mydriatics are not fully understood. We demonstrate that dilation with
either atropine or phenylephrine results in similar enhancements of rod/cone-
and melanopsin- driven pupil responses. 
Purpose: To compare effects of atropine, a muscarinic antagonist, and phenylephrine,
an adrenergic agonist, on consensual pupil responses, and to assess repeatability of
pupil metrics without mydriasis. 
Methods: Right eye pupil responses of 20 adults, aged 21-42, were recorded before
and 45 minutes after instillation of 0.5% atropine or 2.5% phenylephrine in the left eye.
Stimuli were presented to the left eye and included six alternating 1 second (s) 651 nm
“red” and 456 nm “blue” flashes. Metrics included baseline pupil diameter, maximum
constriction, 6 s and 30 s post illumination pupil responses, and early (0-10 s) and late
(10-30 s) areas under the curve. 
Results: Dilation of the stimulated eye with either mydriatic
significantly increased the 6 second post illumination pupil response and early and
late areas under the curve for blue stimuli, and early area under the curve for red
stimuli (P < .05 for all). Melanopsin-driven post illumination pupil responses, achieved
with either phenylephrine or atropine, did not significantly differ from each other (P >
.05 for all). Without mydriasis, intersession intraclass correlation coefficients for pupil
metrics were 0.63 and 0.50 (6 s and 30 second post illumination pupil responses,
respectively), and 0.78 and 0.44 (early and late areas under the curve, respectively) for
blue stimuli, with no significant difference between sessions (P > .05 for all). 
Conclusion: Dilation with phenylephrine or atropine resulted in similar enhancements of
the rod/cone- and melanopsin-driven pupil responses, despite differing mechanisms.
Early pupil metrics without mydriasis demonstrated moderate to good intersession
repeatability.
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Second Revision  
Editors' comments: 
The reviewers make some good points and I advise the authors address these in a revised manuscript. 
Pupil measurements are reported to the tenth of a micron. Please round to the nearest .1 mm in the 
tables and text. 
Completed 
In accordance with the journal instructions for authors, please eliminate the PIPR acronym and spell out 
this phrase. 
Completed 




Thank you for your effort to revise the manuscript. I believe the quality of the paper improved a lot. 
A few issues to address: 
- Line 10-11: The description is not correct. ipRGC does not fire only after short wavelength stimulus. It's 
more sensitive to short-wavelength, but it still response to any light stimulus depending upon the 
luminance level. 
Thank you for your comments. We have corrected this oversight.  
‘Single cell recordings demonstrate sustained firing of intrinsically photosensitive retinal ganglion 
cells after light offset when melanopsin is activated.15 This contributes to the observed, in vivo, 
melanopsin-driven post illumination pupil response which is characterized by a sustained pupil 
constriction following light offset. Melanopsin is most sensitive to short wavelength stimuli.’ 
- Line 179: "MATLAB filtering" is not clear enough. Please describe what kind of filtering method was 
applied. 
This sentence has been re-phrased to draw attention to the detailed filtering details within the 
methods. (Line 116-119) 
‘For figure 2, pupil diameter data were visually inspected subsequent to filtering by a custom 
written MATLAB program described in the methods. Any remaining points that were identified as 
artefacts (i.e. due to blinks) were manually removed prior to averaging.’ (Line 180-183) 
- Line 218-226: I have a little problem with this approach. As many researchers do, it's possible to 
modulate the PLR based on the main contributor (cone, rod, or melanopsin). 
But the problem is that ipRGC is a main conduit of most PLR and if certain factor affect ipRGC, in this 
case, dopamine, it will affect ALL PLRs, not not only melanopsin-mediated component. Some of the 
description here and introduction seem to confuse the role of ipRGC and melanopsin; they are close but 
not identical. ipRGC still control most of PLRs whether melanopsin is triggered or not. Maybe the authors 
make the argument a bit more clear by mentioning this 
Response to review
Thank you for pointing out this distinction. We have now clarified the role of ipRGCs in both rod/cone and 
melanopsin driven pupil pathways in several locations throughout the manuscript. 
  
In the introduction at line 9, we have added the statement, “The intrinsically photosensitive retinal 
ganglion cells are the main conduit of the light mediated afferent pupil pathway for both rod/cone- and 
melanopsin- driven pupil responses.” 
  
We have replaced “ipRGCs” with “melanopsin” in line 15, “Melanopsin is most sensitive to short 
wavelength stimuli.” 
  
We have added at Line 227 that all light information is carried to higher pupil centers via iprgcs, “In this 
study, we examined the effects of different mydriatic drugs on the melanopsin-driven post illumination 
pupil response, as well as the rod/cone-driven pupil response. For both rod/cone- and melanopsin-driven 
pupil responses, light information is primarily carried from the retina to the olivary pretectal nucleus via the 
intrinsically photosensitive retinal ganglion cells.” 
  
At line 265, we added “rod/cone-driven pupil response…” to make the point that the rod/cone pathway 
also goes through ipRGCs, “Future research evaluating the effects of various concentrations of atropine 
on the rod/cone-driven pupil response and melanopsin-driven post illumination pupil response would be 
valuable to determine the nature of atropine’s interactions with intrinsically photosensitive retinal ganglion 
cells.” 
 
In the abstract, we added “rod/cone-“ in addition to “melanopsin-“, in referring to which pupil metrics were 
assessed in this study, “Pupillometry protocols evaluating rod/cone- and melanopsin-driven responses 
often utilize mydriatics to ensure maximal stimulus exposure…” 
 
Finally, the title was changed to reflect the reviewer’s comment, and now reads, “Effects of mydriatics on 
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ABSTRACT 1 
Significance: Pupillometry protocols evaluating rod/cone- and melanopsin-driven responses 2 
often utilize mydriatics to ensure maximal stimulus exposure; however, retinal effects of 3 
mydriatics are not fully understood. We demonstrate that dilation with either atropine or 4 
phenylephrine results in similar enhancements of rod/cone- and melanopsin- driven pupil 5 
responses. 6 
Purpose: To compare effects of atropine, a muscarinic antagonist, and phenylephrine, an 7 
adrenergic agonist, on consensual pupil responses, and to assess repeatability of pupil 8 
metrics without mydriasis. 9 
Methods: Right eye pupil responses of 20 adults, aged 21-42, were recorded before and 45 10 
minutes after instillation of 0.5% atropine or 2.5% phenylephrine in the left eye. Stimuli were 11 
presented to the left eye and included six alternating 1 second (s) 651 nm “red” and 456 nm 12 
“blue” flashes. Metrics included baseline pupil diameter, maximum constriction, 6 s and 30 s 13 
post illumination pupil responses, and early (0-10 s) and late (10-30 s) areas under the 14 
curve. 15 
Results: Dilation of the stimulated eye with either mydriatic significantly increased the 6 16 
second post illumination pupil response and early and late areas under the curve for blue 17 
stimuli, and early area under the curve for red stimuli (P < .05 for all). Melanopsin-driven 18 
post illumination pupil responses, achieved with either phenylephrine or atropine, did not 19 
significantly differ from each other (P > .05 for all). Without mydriasis, intersession intraclass 20 
correlation coefficients for pupil metrics were 0.63 and 0.50 (6 s and 30 second post 21 
illumination pupil responses, respectively), and 0.78 and 0.44 (early and late areas under the 22 
curve, respectively) for blue stimuli, with no significant difference between sessions (P > .05 23 
for all). 24 
Conclusion: Dilation with phenylephrine or atropine resulted in similar enhancements of the 25 
rod/cone- and melanopsin-driven pupil responses, despite differing mechanisms. Early pupil 26 
metrics without mydriasis demonstrated moderate to good intersession repeatability. 27 
Abstract
Melanopsin containing retinal ganglion cells are a unique, intrinsically photosensitive, 1 
subset of ganglion cells located in the inner and outer regions of the inner plexiform layer.1 They 2 
serve as irradiance detectors and have a maximum sensitivity to short-wavelength light 3 
(approximately 482nm).2,3 In addition to intrinsic melanopsin stimulation, photic information is 4 
integrated from extrinsic rod and cone pathways via synaptic connections with bipolar and 5 
dopaminergic amacrine cells.4–9 Intrinsically photosensitive retinal ganglion cells are known to 6 
project to multiple brain regions including the hypothalamic suprachiasmatic nucleus to facilitate 7 
circadian photo-entrainment, the pretectal olivary nucleus to regulate pupil size, and the lateral 8 
geniculate nucleus of the thalamus for image forming visual functions.7,10–14 The intrinsically 9 
photosensitive retinal ganglion cells are the main conduit of the light mediated afferent pupil 10 
pathway for both rod/cone- and melanopsin- driven pupil responses.   11 
Single cell recordings demonstrate sustained firing of intrinsically photosensitive retinal 12 
ganglion cells after light offset when melanopsin is activated.15 This contributes to the observed, 13 
in vivo, melanopsin-driven post illumination pupil response which is characterized by a 14 
sustained pupil constriction following light offset. Melanopsin is most sensitive to short 15 
wavelength stimuli.15 Post illumination pupil responses can be quantified through chromatic 16 
pupillography, which, as a biomarker for melanopsin function, is increasingly employed in 17 
clinical and research areas of ophthalmology, psychology and chronobiology.16 Melanopsin-18 
driven post illumination pupil responses have not been found to vary with age or refractive 19 
error.17,18 However, altered melanopsin function has been demonstrated in ocular pathologies 20 
including glaucoma,19–21 age-related macular degeneration,22,23 diabetes,24,25 and retinitis 21 
pigmentosa.26  22 
The broad application, and the wide variability of pupillography protocols, motivated a 23 
recent review outlining minimum standards in pupillography.27 Pupil status, i.e. whether the pupil 24 
has undergone pharmacological mydriasis during pupillography, is an important variable 25 
discussed within this aforementioned review. A natural pupil will fluctuate in size during stimuli 26 
Manuscript
presentations, subsequently altering retinal irradiance.16 This is particularly problematic when 27 
Newtonian, full field, stimuli are presented. Retinal irradiance can be controlled by presenting 28 
Maxwellian stimuli, by using artificial pupils or by dilating the stimulated eye with mydriatics 29 
whilst recording the consensual pupil response.27 Maxwellian apparatus is typically custom-built 30 
therefore, dilation is often favored. Dilation is achieved using, either alone or in combination, 31 
muscarinic antagonists, such as tropicamide, cyclopentolate, or atropine, or alpha-adrenergic 32 
agonists, such as phenylephrine. The extent to which these mydriatic drugs differentially 33 
influence retinal physiology is not fully understood.28,29  34 
Atropine eye drops are increasingly prescribed to reduce myopia progression in 35 
children.30–32  However, the exact mechanism by which atropine protects against myopia is 36 
unknown. It has been hypothesized that atropine may function to control myopia through a 37 
dopaminergic pathway via a retinal neurochemical cascade.29,33 Interestingly, retinal dopamine 38 
has been implicated in the protection against myopia.28,34 In addition, retinal dopamine 39 
concentration has been found to increase with light exposure35 and by intravitreal injections of 40 
atropine to the chick eye.28  Retinal dopamine is diurnally released from dopaminergic amacrine 41 
cells, in part, via ‘light’ signals from intrinsically photosensitive retinal ganglion cells,36–38 and has 42 
been linked to the regulation of melanopsin mRNA.39 Therefore, intrinsically photosensitive 43 
retinal ganglion cells may be implicated in the mechanism by which atropine constrains eye 44 
growth. If so, instillation of muscarinic antagonists prior to pupillometry may present a 45 
confounding factor when evaluating melanopsin function.  46 
The present study utilized Newtonian stimuli to examine the effects of two different 47 
mydriatic agents (atropine 0.5%, a muscarinic antagonist, and phenylephrine 2.5%, an 48 
adrenergic agonist) on rod/cone- and melanopsin- driven post illumination pupil responses. 49 
While enhancement of consensual pupil responses is anticipated with both mydriatic agents due 50 
to higher retinal irradiance, differential, drug-specific effects may also be postulated resulting 51 
from the differing drug mechanisms. Phenylephrine has no documented myopia control effects 52 
or interactions with dopaminergic or melanopsin pathways, and will act as a control in this 53 
experiment. Understanding the effects of these mydriatics is important in protocol development. 54 
Differences in mydriatic effects may elucidate interactions between muscarinic, adrenergic, and 55 
melanopsin pathways. The intersession repeatability of rod/cone- and melanopsin-driven pupil 56 
metrics without dilation was also investigated in the present study, providing valuable 57 
information for chromatic pupillometry studies where mydriasis is contraindicated or unavailable. 58 
Methods 59 
Twenty healthy adults, aged 21-42 years, were recruited from the University of 60 
Houston's College of Optometry faculty, staff and student population. The study was approved 61 
by the institutional review board at the University of Houston and followed the tenets of the 62 
Declaration of Helsinki. Interested individuals were fully informed on the procedures and written 63 
consent was obtained.  64 
Initial lab visits were scheduled between 9:00 am and 4.30 pm. Repeat sessions were 65 
scheduled at the same time of day for each subject to minimize effects of circadian variation on 66 
the post illumination pupil response.40 Visual acuity was measured with habitual correction, and 67 
an anterior eye exam using slit lamp biomicroscopy was performed to confirm open anterior 68 
chamber angles and suitability for dilation. Best corrected visual acuity for all subjects was 69 
20/25 or better. No subjects had ocular pathology, nor had they been dilated in the five days 70 
prior to the experiment. No subjects were taking prescription or recreational drugs known to 71 
affect pupil size or sleep, and no subjects reported being pregnant or breastfeeding.  72 
Experimental protocol 73 
Each subject underwent two experimental sessions. At the first visit, spherical equivalent 74 
refraction was calculated for each eye following non-cycloplegic autorefraction (WAM-5000, 75 
Grand Seiko, Japan), and axial length and pupil diameter were determined (LenStar, Haag-76 
Streit, Germany). Following these measures, non-mydriatic pupillometry was performed. For 77 
pupillometry, stimuli were presented to the left eye, and the consensual pupil response was 78 
measured in the right eye. The left eye was then dilated with either 2.5% phenylephrine 79 
(Paragon BioTeck, USA) or 0.5% atropine (Greenpark Compounding Pharmacy, Houston, TX, 80 
USA). An atropine concentration of 0.5% was chosen to minimize recovery time between visits 81 
whilst still eliciting a significant effect on the pupil. The pharmacological agent used at the first 82 
session was randomized. Two drops of the selected mydriatic were delivered five minutes apart 83 
to the left eye. After a 45-minute dilation period, diameter of the dilated left pupil was measured, 84 
and pupillometry was repeated. To allow drug wash-out, visit two was scheduled at least five 85 
days later if phenylephrine 2.5% had been instilled first, and at least ten days later if atropine 86 
0.5% had been instilled first. 87 
Pupillometry procedure 88 
The pupillometry protocol has been described in detail elsewhere.41 Subjects were fitted 89 
with a frame mounted 60 Hz infrared illumination eye tracker (ViewPoint EyeTracker, Arrington 90 
Research, USA) to record pupil diameter of the right eye. The system provides better than 0.03 91 
mm resolution for pupil diameter. The infrared light emitting diode light source has a lambda 92 
max of 943 nm with a half-max width of 46 nm (Spectrometer, Ocean Optics, USA). At the start 93 
of each session, the camera was positioned and focused on the iris, and pupil diameter was 94 
calibrated by capturing an image of a 5 mm printed black circle positioned close to the subject’s 95 
corneal plane. Following calibration, the room lights were switched off, and subjects dark 96 
adapted behind a black-out curtain for five minutes (<0.1 lux). The five minute dark adaptation 97 
period allowed adaptation of cones; rods and ipRGCs were not expected to be fully adapted. 98 
Subjects were then instructed to place their head on a chinrest with a light emitting diode-driven 99 
Ganzfeld system (Color Burst, Espion, Diagnosys LLC, USA) centered 10 mm in front of the left 100 
eye. Subjects viewed a red fixation point at approximately 3 m with the right eye; the single red 101 
fixation point was used to minimize accommodation cues and preclude a light-driven pupil 102 
response. Baseline pupil diameter was recorded for 10 seconds, then six alternating 1 second 103 
long wavelength “red” and short wavelength “blue” Newtonian stimuli were presented to the left 104 
eye, with a 60 second interstimulus interval (Figure 1). Red stimuli, always presented first, were 105 
651 nm with a half-max width of 25 nm (Spectroradiometer CS1W, Konica Minolta, USA) and 106 
set to 33.3 cd/m2, and with a measured corneal irradiance of 5.58 x 1013 photons cm-2s-1 (Power 107 
Meter, Newport, USA). The pupillary light reflex to red stimuli is known to be primarily driven by 108 
medium and long wavelength cones. Blue stimuli were 456 nm (half-max width of 20 nm) and 109 
set to 16.67 cd/m2, with a measured corneal irradiance of 5.85 x 1013 photons cm-2s-1. These 110 
intensities of red and blue stimuli were chosen as they have similar photon flux and elicit similar 111 
pupil constriction. The pupillary light reflex to blue stimuli is driven by rods, short, medium, and 112 
long wavelength cones, and the intrinsically photosensitive retinal ganglion cells.42 The blue 113 
stimulus used in the present study is above the melanopsin threshold.10,43 Previous findings 114 
show that these intensities of red and blue stimuli elicit approximately equal pupil constriction 115 
when the stimulated eye is dilated with both 2.5% phenylephrine and 1% tropicamide.44 116 
Data analysis 117 
Raw pupil data were analysed off-line using a custom program (MATLAB, The 118 
MathWorks, Inc., USA). Blinks were identified as intervals of pupil aspect ratio outside 6 119 
standard deviations of the mean pupil aspect ratio during stable fixation and were removed from 120 
the data file along with samples that were deemed poor quality by the instrument. Individual 121 
data were then exported to an Excel file (Microsoft Office 2013). Data for the three red stimuli 122 
were averaged together, and data for the three blue stimuli were averaged together. Pupil 123 
metrics used to evaluate the pupil response included baseline pupil diameter, relative maximum 124 
constriction, relative 6 s post illumination pupil response, relative 30 s post illumination pupil 125 
response, and early and late area under the curve, defined in Table 1. The baseline pupil 126 
diameter was calculated by averaging pupil diameter during the 10 s recording period prior to 127 
the first red stimulus. Relative responses (maximum constriction, 6 s post illumination pupil 128 
response, and 30 s post illumination pupil response) were calculated based as the percentage 129 
change from baseline. The 6 s and 30 s post illumination pupil response were calculated as the 130 
pupil size averaged over 6–7 s and 30–31 s, respectively, after each stimulus offset. Early and 131 
late areas under the curve were computed for the intervals post stimulus offset 0 to 10 s and 10 132 
to 30 s, as the trapezoidal approximation of the integral of 100% minus the interpolated percent 133 
pupil diameter (i.e., the difference between the pupil and baseline) for the respective intervals.  134 
Statistical analysis  135 
Statistical analysis was performed in SPSS (SPSS, IBM Corp., USA). Data are 136 
presented as mean ± standard deviation. Data were analyzed for normality using the Shapiro-137 
Wilk test. Parametric data were analyzed using a paired sample t-test. Non-parametric data 138 
were analyzed using a related-sample Wilcoxon signed rank test. In all instances, P < 0.05 was 139 
considered statistically significant. A two-way mixed effects single measurement intraclass 140 
correlation coefficient for absolute agreement was calculated to determine the repeatability 141 
of non-mydriatic pupil metrics, and interpreted based on recently published guidance.45 The 142 
intrasession and intersession pupil metrics for red and blue stimuli were calculated and 143 
compared across four conditions: non-mydriatic pupillometry during the phenylephrine session 144 
(from this point on referred to as non-mydriatic session 1), non-mydriatic pupillometry during the 145 
atropine session (non-mydriatic session 2), 45 minutes post-phenylephrine instillation, and 45 146 
minutes post-atropine instillation. Pupil metrics were compared using a paired sample t-test or 147 
appropriate non-parametric test where indicated.  148 
Results  149 
One subject’s data were excluded from analysis due to extreme fluctuations in the 150 
demarcation of the pupil boundary during all sessions. The remaining subjects (n = 19) had a 151 
mean age of 28.1 ± 5.1 years and included 6 males and 13 females. Mean spherical equivalent 152 
refraction of right eyes was -1.91 ± 2.08 D (range -5.75 to +1.87 D) and of left eyes was -2.11 ± 153 
2.22 D (range -6.31 to +1.62 D), with no significant difference between eyes (P = .09). Mean 154 
axial length of right eyes was 24.33 ± 1.21 mm (range 22.49 to 27.57 mm) and of left eyes was 155 
24.31 ± 1.22 mm (range 22.35 to 27.65 mm), with no significant difference between eyes (P = 156 
.64).   157 
Pupil diameter in photopic room illumination (approximately 400 lux) prior to non-158 
mydriatic pupillometry was 4.8 ± 0.8 mm for the left eye and 4.7 ± 0.8 mm for the right eye, with 159 
no significant differences between eyes (P = .46). The pupil diameter of the left eye 45 minutes 160 
after dilation with phenylephrine increased to 6.3 ± 1.1 mm (P < .0001), and after dilation with 161 
atropine increased to 8.2 ± 0.5 mm (P < .0001). Pupil diameter after atropine was significantly 162 
larger than after phenylephrine (P < .0001). Pupil area under photopic conditions of the left eye 163 
during non-mydriatic sessions was 18.0 mm2, after phenylephrine was 30.7 mm2, and after 164 
atropine was 53.2 mm2.   165 
For non-mydriatic conditions, following 5 minutes of dark adaptation, the right eye pupil 166 
diameter increased to 6.2 ± 1.1 mm (for non-mydriatic session 1, P < .0001), and to 6.1 ± 0.6 167 
mm (for non-mydriatic session 2, P < .0001) with no significant differences between right eye 168 
pupil diameters during non-mydriatic sessions prior to stimulus onset (P = .63). When the left 169 
eye was dilated with phenylephrine, dark adapted right eye pupil diameter was 6.1 ± 0.9 mm, 170 
and when the left eye was dilated with atropine, dark adapted right eye pupil diameter was 6.2 ± 171 
0.7 mm. These pupil diameters were not significantly different from each other (P = .9) or from 172 
their respective non-mydriatic measures (P = .34 and .3 respectively). Dark adapted pupil 173 
diameter of the left eye prior to pupillometry was not measured as the light stimulus equipment 174 
was placed in front of the left eye precluding imaging. 175 
For all sessions, pupils re-dilated rapidly following red stimulus offset, and re-dilated at a 176 
slower rate following blue stimulus offset, i.e. pupils demonstrated an enhanced post 177 
illumination pupil response following blue stimuli, which is the signature for a melanopsin-driven 178 
pupil response. These dynamics resulted in a larger percentage for 6 s and 30 s post 179 
illumination pupil response, and a larger value for early and late area under the curve for blue 180 
stimuli versus red stimuli for all conditions. Dynamic pupil responses for all pupillometry 181 
sessions are presented in Figure 2. For figure 2, pupil diameter data were visually inspected 182 
subsequent to filtering by a custom written MATLAB program described in the methods. Any 183 
remaining points that were identified as artefacts (i.e. due to blinks) were manually removed 184 
prior to averaging. Relative response diameters for the three red stimuli were averaged 185 
together, and diameters for the three blue stimuli were averaged together. Associated pupil 186 
metrics are shown Table 2.  187 
Non-mydriatic session 1 versus 2 188 
Non-mydriatic sessions were conducted on separate days to assess repeatability. There 189 
was no significant difference in the time of day of the visits (P = .89). Pupil metrics did not differ 190 
significantly across non-mydriatic sessions (P > .05 for all metrics). Intersession intraclass 191 
correlation coefficient [95% confidence interval] demonstrate moderate to good repeatability for 192 
maximum constriction, 6 s post illumination pupil response, and early area under the curve for 193 
both red and blue stimuli (Table 3). The 30 s post illumination pupil response for red stimuli and 194 
the late area under the curve for blue stimuli revealed an intraclass correlation coefficient value 195 
below 0.5, indicating poor repeatability. The 95% confidence intervals also suggest poor 196 
repeatability of the 30 s post illumination pupil response for blue stimuli and late area under the 197 
curve for red stimuli. Bland-Altman analysis examining the agreement of repeated non-mydriatic 198 
measures demonstrates close to zero bias between sessions (i.e. the mean difference between 199 
sessions is close to zero) and good agreement for maximum constriction, 6 s post illumination 200 
pupil response, and early area under the curve for red and blue stimuli (Figure 3).  201 
Non-mydriatic versus phenylephrine session 202 
Following phenylephrine induced mydriasis of the stimulated eye, maximum constriction 203 
of the consensual pupil increased significantly for red (P < .0001) but not for blue (P = .1) 204 
stimuli. The consensual post illumination pupil response was enhanced, as seen by a 205 
significantly higher 6 s post illumination pupil response (P = .045 for red stimuli; P = .01 for blue 206 
stimuli), and early (P = .01 for red stimuli; P = .001 for blue stimuli) and late area under the 207 
curve values (P = .03 for red stimuli; P = .01 for blue stimuli). Differences in the 30 s post 208 
illumination pupil response did not reach significance (P = .06 for red stimuli; P = .47 for blue 209 
stimuli) (Table 2, Figure 4).  210 
Non-mydriatic versus atropine session 211 
Following atropine induced mydriasis of the stimulated eye, maximum constriction of the 212 
consensual pupil increased for red (P = .05) and blue (P = .18) stimuli, but neither increase was 213 
statistically significant. The consensual post illumination pupil response was enhanced for blue 214 
stimuli as seen by the significantly higher 6 s and 30 s post illumination pupil response (P = .03 215 
and .01, respectively), and early and late area under the curve values (P = .01 and .02, 216 
respectively). The early area under the curve also significantly increased for red stimuli (P = 217 
.047) (Table 2, Figure 4). 218 
Phenylephrine versus atropine session 219 
 Maximum constriction was not significantly different after phenylephrine compared to 220 
after atropine for red or blue stimuli (P = .36 and .69 respectively). For blue stimuli, there were 221 
no significant differences between phenylephrine and atropine post illumination pupil response 222 
metrics. For red stimuli, the 6 s and 30 s post illumination pupil response were significantly 223 
higher (P =.04 and .02 respectively) after phenylephrine compared to atropine.  224 
Discussion 225 
 In this study, we examined the effects of different mydriatic drugs on the melanopsin-226 
driven post illumination pupil response, as well as the rod/cone-driven pupil response. For both 227 
rod/cone- and melanopsin- driven pupil responses, light information is primarily carried from the 228 
retina to the olivary pretectal nucleus via intrinsically photosensitive retinal ganglion cells. As 229 
expected, dilation of the stimulated eye with either mydriatic (phenylephrine, an adrenergic 230 
agonist, or atropine, a muscarinic antagonist) enhanced several consensual post illumination 231 
pupil metrics. Interestingly, there were no significant differences between the effects of atropine 232 
0.5% and phenylephrine 2.5% on the melanopsin-driven pupil response, despite greater dilation 233 
and higher levels of retinal irradiance achieved with atropine. Furthermore, we demonstrated 234 
that rod/cone- and melanopsin- driven pupil metrics, assessed without mydriatics, show 235 
moderate to good intersession repeatability and agreement when Newtonian stimuli are 236 
presented.  237 
In light of the emerging role of atropine in myopia management,46 we hypothesized that 238 
through evaluating the influence of different mydriatics on the melanopsin-driven post 239 
illumination pupil response, insight may be gained into the mechanism by which atropine acts 240 
on axial growth regulation. Dilation with either phenylephrine or atropine increased post 241 
illumination pupil metrics to red and blue stimuli (Table 2). The increase in maximum 242 
constriction was statistically significant with phenylephrine dilation and for red stimuli only. This 243 
is unlikely to be a clinically significant result. Statistically significant increases were also noted 244 
for early metrics (< 10 seconds following stimulus offset) of the post illumination pupil response 245 
to blue stimuli. Blue stimuli activate both rod/cone- and melanopsin-driven pupil pathways. For a 246 
1 second blue stimulus, the pupil response up to 1.7 seconds post stimulus is attributed to major 247 
inputs from rods and intrinsically photosensitive retinal ganglion cells, with minimal cone 248 
contribution.47 Intrinsically photosensitive retinal ganglion cells are distributed throughout the 249 
retina with wide dendritic coverage.48 Previous research has shown the post illumination pupil 250 
response increases with stimulus intensity15,44,49 and pupil size.50 Therefore, it is to be expected 251 
that with a larger pupil size of the stimulated eye, a greater number of intrinsically photosensitive 252 
retinal ganglion cells will be directly activated by the blue stimulus, and the melanopsin-driven 253 
post illumination pupil metrics enhanced, as observed here.  254 
Remarkably, dilation of the stimulated eye with either mydriatic resulted in comparable 255 
enhancement effects despite a 32% larger photopic pupil diameter following dilation with 256 
atropine compared to phenylephrine. It is possible that saturation of the melanopsin-driven 257 
photoresponse occurred and resulted in a maximal post illumination pupil response with 258 
phenylephrine dilation (6.3 mm). However, our previous study,18 as well as others, 259 
demonstrates that a stronger post illumination pupil response can be elicited with higher 260 
stimulus intensity, so it is unlikely that the response was saturated at the stimulus intensity used 261 
here. Alternatively, atropine instillation may have inhibited the expected boost in post 262 
illumination pupil response with increased pupil size. Future research evaluating the effects of 263 
various concentrations of atropine on the rod/cone-driven pupil response and melanopsin-driven 264 
post illumination pupil response would be valuable to determine the nature of atropine’s 265 
interactions with intrinsically photosensitive retinal ganglion cells. Future studies should include 266 
low dose atropine (0.01%), which is suggested to control myopia via a neurochemical cascade 267 
that begins with muscarinic receptors in the retina, with the aim of elucidating potential retinal 268 
sites of atropine’s action.29 To control pupil size, custom built Maxwellian presented stimuli, or 269 
artificial pupils, should be employed to standardize retinal irradiance within and between 270 
subjects.16,27  271 
Phenylephrine and atropine produce mydriasis through different mechanisms, with 272 
phenylephrine stimulating the dilator muscle and atropine blocking the sphincter muscle, as well 273 
as the ciliary muscle, leading to mydriasis in conjunction with cycloplegia. As a consequence, 274 
accommodative tone in the stimulated eye will have differed between the two mydriatic 275 
protocols in the present study. However, it is unlikely that accommodation in the fixating, 276 
consensual eye was affected. The experimental set up was designed to minimize stimulating 277 
accommodation in the fixating eye.  278 
It has been suggested that mydriatics are not necessary in pupillometry protocols if the 279 
intensity of the light stimulus is sufficiently bright; Bruijel, et al. (2016) intensified blue stimuli to 280 
15.11 log photon flux without mydriasis and revealed reasonable agreement to an earlier 281 
protocol which incorporated mydriasis.51 Authors also reported that pupillometry without 282 
mydriasis had a very high test-retest reliability for post illumination pupil metrics across 283 
consecutive days and across seasons; albeit, reliability was lower across seasons compared to 284 
across consecutive days.51 The blue stimulus in the present study was 13.77 log photon flux, 285 
presented over a wide visual field of approximately 140 degrees, and was shown to be 286 
sufficiently bright to elicit a melanopsin-driven pupil response. The results of the present study 287 
provide further evidence that recording the post illumination pupil response without mydriasis of 288 
the stimulated eye is reliable and repeatable and should be acceptable if pharmacological pupil 289 
dilation is contraindicated or unavailable. Protocols without mydriasis have fewer ethical and risk 290 
assessment considerations, and benefits include conserving research time and minimizing both 291 
ocular and systemic risks of mydriatic drug instillation. In addition, standardizing retinal 292 
irradiance by presenting Maxwellian stimuli or by using artificial pupils will likely boost 293 
repeatability metrics of non-mydriatic protocols. 294 
While we show that non-mydriatic pupil metrics did not differ significantly across 295 
sessions, some variability was present (Table 3). The intraclass correlation coefficient suggests 296 
moderate to good repeatability for early metrics of the post illumination pupil response (6 s post 297 
illumination pupil response and early area under the curve) and poor repeatability for late 298 
metrics of the response (30 s post illumination pupil response and late area under the curve). 299 
We speculate that early metrics are predominantly driven by melanopsin activation, whereas 300 
later metrics are influenced by autonomic tone once intrinsically photosensitive retinal ganglion 301 
cells decrease firing, and therefore subject to greater variability. Another factor contributing to 302 
variability is habitual light exposure. Abbott, et al. (2018) demonstrated that an enhanced post 303 
illumination pupil response was evident with greater habitual light exposure in adult 304 
participants.18 Similarly, Ostrin (2018) showed that the 6 s post illumination pupil response and 305 
early area under the curve to high intensity blue stimuli were associated with light exposure in 306 
the 24 hours prior to pupillometry in children.44 Prior light exposure may explain the variability 307 
across sessions and between subjects. Light exposure data were not collected in this 308 
experiment and should be considered in future research. Furthermore, pupil size can be 309 
affected by several other variables, including age, attention, accommodative tone, fatigue, and 310 
autonomic input, including alterations in systemic adrenaline circulation.52,53 Whilst intrinsic 311 
inputs to the pupil cannot be entirely eliminated, efforts were made to minimize these factors. All 312 
experiments were conducted in a controlled dark environment, with fixation directed at a 313 
minimally accommodative target, mydriatic selection was randomized, and pupillometry was 314 
performed at the same time of day. 315 
In conclusion, dilation with either phenylephrine 2.5% or atropine 0.5% resulted in similar 316 
short-term enhancement effects on rod/cone- and melanopsin- driven pupil responses, despite 317 
differing mechanisms of mydriatic action and differential effects on pupil size of the stimulated 318 
eye. Furthermore, we have demonstrated that non-mydriatic post illumination pupil metrics 319 
within 10 seconds of stimulus offset show moderate to good repeatability and agreement 320 
between across different days. 321 
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Figure legends  506 
Figure 1: Pupillometry protocol. Subjects dark adapted for 5 minutes. Baseline (BL) pupil 507 
diameter was recorded for 10 seconds (s), then six alternating red or blue 1 second stimuli were 508 
presented to the left eye, with a 60 second interstimulus interval (ISI) between each stimulus 509 
presentation. 510 
Figure 2: Mean relative pupil diameter of right eyes (n=19) before (-5 s to 0 s), during (0 s to1 s) 511 
and after (1 s to 32 s) 1 second red and blue stimuli presented to the left eye for four conditions: 512 
A) non-mydriatic and 45 minutes post-phenylephrine, and B) non-mydriatic and 45 minutes 513 
post-atropine. Shaded areas represent 95% confidence intervals. 514 
Figure 3: Bland-Altman plots for non-mydriatic sessions 1 and 2 for maximum constriction for 515 
red (A) and blue (B) stimuli; 6 s post illumination pupil response for red (C) and blue (D) stimuli; 516 
and early area under the curve for red (E) and blue (F) stimuli. Dashed lines represent the mean 517 
difference between sessions. Dotted lines represent 95% limits of agreement.  518 
Figure 4: Maximum (Max.) constriction for red (A) and blue (B) stimuli; 6 s post illumination pupil 519 
response for red (C) and blue (D) stimuli; and early area under the curve for red (E) and blue (F) 520 
stimuli, during each pupillometry condition [non-mydriatic session 1 (NM 1), 45 minutes post-521 
phenylephrine (Phenyl), non-mydriatic session 2 (NM 2), and 45 minutes post-atropine 522 
(Atropine)]. *indicates significance at P ≤ .05 for non-mydriatic compared to mydriatic conditions.523 
 524 
Table 1: Pupil metrics used to quantify the post illumination pupil response (PIPR) 




Mean dark-adapted pupil diameter 10 s prior 
to first stimulus 
Maximum 
constriction 
% change from 
baseline pupil 
diameter 
Maximum pupil constriction 
6 s PIPR 
% change from 
baseline pupil 
diameter 
Mean pupil diameter 6–7 s after stimulus 
offset 
30 s PIPR 
% change from 
baseline pupil 
diameter 
Mean pupil diameter 30–31 s after stimulus 
offset 
Early AUC No unit 
Integral of 100% minus the interpolated % 
pupil diameter, 0–10 s after stimulus offset 
Late AUC No unit 
Integral of 100% minus the interpolated % 
pupil diameter, 10–30 s after stimulus offset 
Post illumination pupil response (PIPR), area under the curve (AUC) 
Tables 1-3
Table 2: Pupil metrics for 1 second red and blue stimulations during four experimental 
sessions. Metrics include maximum constriction (% change from baseline), 6 s and 30 s post 
illumination pupil response (PIPR, % change from baseline), and early and late area under 
the curve (AUC, unitless).  
 
Pupil Metric 
































































































Post illumination pupil response (PIPR), area under the curve (AUC), *P < .05 for non-
mydriatic versus mydriatic conditions 
Table 3: Intraclass correlation coefficient [95% confidence interval] for pupil metrics 
compared across non-mydriatic sessions 1 and 2 on different days. Metrics include 
maximum constriction, the 6 s and 30 s post illumination pupil response (PIPR) and early 
and late areas under the curve (AUC).  
 
Pupil Metric 
Intraclass Correlation Coefficient  
Red Blue 
Maximum constriction 0.83 [0.61 to 0.93] 0.77 [0.50 to 0.91] 
6 s PIPR 0.59 [0.20 to 0.82] 0.63 [0.26 to 0.84] 
30 s PIPR 0.30 [-0.19 to 0.66] 0.50 [0.09 to 0.77] 
Early AUC 0.62 [0.24 to 0.84] 0.78 [0.52 to 0.91] 
Late AUC 0.53 [0.10 to 0.79] 0.44 [-0.02 to 0.74] 















































































































































































































































Mean Early AUC (unitless)
A
F
D
B
C
E
Figure 3
Figure 4
